Featured: Independent Wellness Recognized for Provider-Led GLP-1 Care in 2026 Independent Wellness Recognized for Provider-Led GLP-1 Care in 2026 Independent Wellness has been recognized as a top GLP-1 telehealth program for provider access, highlighting what truly matters in modern medical weight loss personalized care, ongoing support, and direct access to a licensed clinician
patent for semaglutide expires March 20, 2026, but other patents may extend exclusivity until December 5, 2031
Without building new habits around food, will all their cravings instantly return as their body seeks out the nutrients they have been missing
The same dose that worked initially may no longer produce the same appetite-suppressing or metabolic effects
HOW WAS THIS STUDY CONDUCTED
Book a same-day or next-day appointment for your initial consultation today!